Power Law company profile

Transcenta

Biotech & Life Sciences · Suzhou Shi, China · Founded 2019 · IPO 2021 Unicorn

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture

Valuation

$1.00B

Market cap · 2026

Revenue

$1.6M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

10 investors on Transcenta's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

HongShan

Lilly Asia Ventures

ARCH Venture Partners

Temasek

Series B+ 6 investors entered at this stage

China Merchants Capital

Fortune Venture

China Structural Reform Fund

Country Garden

Qatar Investment Authority

Teng Yue Partners

Global footprint

Where Transcenta has talent and traffic

Workforce by country

4 countries with
team presence

🇨🇳 China68.9%

🇺🇸 United States28.3%

🇭🇰 Hong Kong1.8%

🇪🇸 Spain1.8%

4 countries shown

Web traffic by country

5K monthly visits
across markets

🇺🇸 United States50%

🏳️ Korea24%

🏳️ Republic of20%

🇮🇳 India6%

🇭🇰 Hong Kong0%

Top 5 markets shown

Patent intelligence

$9M patent portfolio · 54 active families

Estimated portfolio value

$9M

0.90% of market cap · 34.3× smaller than top peer Acceleron Pharma ($309M)

54 active patent families

Where Transcenta innovates AntagonistL1Combination therapyDiseaseAntiendomysial antibodies

Where Transcenta concentrates vs peers

Each axis is a top-10 topic across Transcenta and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Transcenta

An AI-synthesized read of the highest-engagement posts about Transcenta on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Transcenta on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles